InfuSystem Holdings (INFU) Income from Non-Controlling Interests (2011 - 2012)
InfuSystem Holdings (INFU) posted Income from Non-Controlling Interests of $1000.0 for Q1 2012, down 96.55% on a QoQ basis from $29000.0 in Q4 2011.
InfuSystem Holdings (INFU) Income from Non-Controlling Interests (2011 - 2012) Analysis & Trends
InfuSystem Holdings' Income from Non-Controlling Interests history runs 2 years deep, the most recent figure standing at $1000.0 for Q1 2012.
- Quarterly Income from Non-Controlling Interests changed N/A year-over-year to $1000.0 in Q1 2012, while the trailing twelve-month figure through Sep 2012 was $30000.0 (changed N/A YoY) and the FY2011 annual result came in at -$72000.0, changed N/A from the prior year.
- Income from Non-Controlling Interests was $1000.0 for Q1 2012 at InfuSystem Holdings, down from $29000.0 in the prior quarter.
- Across five years, Income from Non-Controlling Interests topped out at $29000.0 in Q4 2011 and bottomed at -$81000.0 in Q2 2011.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Inc. Minority (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 184.21 Bn | 176.92 Bn | 6.27 Bn | - |
| 2 | Stryker | 128.90 Bn | 126.02 Bn | 3.81 Bn | - |
| 3 | Medtronic | 109.00 Bn | 99.78 Bn | 6.41 Bn | 16.00 Mn |
| 4 | Boston Scientific | 68.62 Bn | 67.16 Bn | 3.61 Bn | -2.00 Mn |
| 5 | Edwards Lifesciences | 47.39 Bn | 43.72 Bn | 1.29 Bn | - |
| 6 | GE HealthCare Technologies | 28.44 Bn | 26.16 Bn | 1.98 Bn | 22.00 Mn |
| 7 | Dexcom | 28.39 Bn | 27.27 Bn | 750.30 Mn | - |
| 8 | Smith & Nephew | 27.03 Bn | 26.46 Bn | - | - |
| 9 | Koninklijke Philips | 25.55 Bn | 22.43 Bn | 2.07 Bn | -5.85 Mn |
| 10 | InfuSystem Holdings | 189.58 Mn | 187.47 Mn | 19.68 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2012 | 1,000.00 |
| Dec 31, 2011 | 29,000.00 |
| Sep 30, 2011 | -67,000.00 |
| Jun 30, 2011 | -81,000.00 |